project id: TCGA-ESCA; case submitter id: TCGA-LN-A49O; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; age at index: 47; days to birth: -17237; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1964; age at diagnosis: 17237; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIA; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 408.0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; days to collection: 605; days to sample procurement: 0; initial weight: 330.0; portion submitter id: TCGA-LN-A49O-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 2.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 23.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;